Sangam: A Confluence of Knowledge Streams

Developing and Validating Multi-Modal Models for Mortality Prediction in COVID-19 Patients: a Multi-center Retrospective Study

Show simple item record

dc.creator Wu, Joy T.
dc.creator de la Hoz, Miguel Á. A.
dc.creator Kuo, Po-Chih
dc.creator Paguio, Joseph A.
dc.creator Yao, Jasper S.
dc.creator Dee, Edward C.
dc.creator Yeung, Wesley
dc.creator Jurado, Jerry
dc.creator Moulick, Achintya
dc.creator Milazzo, Carmelo
dc.creator Peinado, Paloma
dc.creator Villares, Paula
dc.creator Cubillo, Antonio
dc.creator Varona, José F.
dc.creator Lee, Hyung-Chul
dc.creator Estirado, Alberto
dc.date 2022-07-11T15:23:33Z
dc.date 2022-07-11T15:23:33Z
dc.date 2022-07-05
dc.date 2022-07-10T03:21:47Z
dc.date.accessioned 2023-02-17T20:05:19Z
dc.date.available 2023-02-17T20:05:19Z
dc.identifier https://hdl.handle.net/1721.1/143642
dc.identifier Wu, Joy T., de la Hoz, Miguel Á. A., Kuo, Po-Chih, Paguio, Joseph A., Yao, Jasper S. et al. 2022. "Developing and Validating Multi-Modal Models for Mortality Prediction in COVID-19 Patients: a Multi-center Retrospective Study."
dc.identifier PUBLISHER_CC
dc.identifier.uri http://localhost:8080/xmlui/handle/CUHPOERS/242102
dc.description Abstract The unprecedented global crisis brought about by the COVID-19 pandemic has sparked numerous efforts to create predictive models for the detection and prognostication of SARS-CoV-2 infections with the goal of helping health systems allocate resources. Machine learning models, in particular, hold promise for their ability to leverage patient clinical information and medical images for prediction. However, most of the published COVID-19 prediction models thus far have little clinical utility due to methodological flaws and lack of appropriate validation. In this paper, we describe our methodology to develop and validate multi-modal models for COVID-19 mortality prediction using multi-center patient data. The models for COVID-19 mortality prediction were developed using retrospective data from Madrid, Spain (N = 2547) and were externally validated in patient cohorts from a community hospital in New Jersey, USA (N = 242) and an academic center in Seoul, Republic of Korea (N = 336). The models we developed performed differently across various clinical settings, underscoring the need for a guided strategy when employing machine learning for clinical decision-making. We demonstrated that using features from both the structured electronic health records and chest X-ray imaging data resulted in better 30-day mortality prediction performance across all three datasets (areas under the receiver operating characteristic curves: 0.85 (95% confidence interval: 0.83–0.87), 0.76 (0.70–0.82), and 0.95 (0.92–0.98)). We discuss the rationale for the decisions made at every step in developing the models and have made our code available to the research community. We employed the best machine learning practices for clinical model development. Our goal is to create a toolkit that would assist investigators and organizations in building multi-modal models for prediction, classification, and/or optimization.
dc.format application/pdf
dc.language en
dc.publisher Springer International Publishing
dc.relation https://doi.org/10.1007/s10278-022-00674-z
dc.rights Creative Commons Attribution
dc.rights https://creativecommons.org/licenses/by/4.0/
dc.rights The Author(s)
dc.source Springer International Publishing
dc.title Developing and Validating Multi-Modal Models for Mortality Prediction in COVID-19 Patients: a Multi-center Retrospective Study
dc.type Article
dc.type http://purl.org/eprint/type/JournalArticle


Files in this item

Files Size Format View
10278_2022_Article_674.pdf 1.670Mb application/pdf View/Open

This item appears in the following Collection(s)

  • DSpace@MIT [2699]
    DSpace@MIT is a digital repository for MIT's research, including peer-reviewed articles, technical reports, working papers, theses, and more.

Show simple item record

Search DSpace


Advanced Search

Browse